Reports
Sale
Global Drug Discovery and Development Solutions Market Size: By Service Type: Medicinal Chemistry, Biology Services, Drug Metabolism, Pharmaceutical Services, Pharmacokinetics, Others; By Drug Type; By Process; By Technology; By Mode; By Therapeutic Area; By End Use; Regional Analysis; Competitive Landscape; 2024-2032
Global Drug Discovery and Development Solutions Market Outlook
The global drug discovery and development solutions market is expected to grow at a CAGR of 13% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to be a Significant Regional Market for the Drug Discovery and Development Solutions Industry
The global market for drug discovery and development solutions is significantly aided by the industry growth in North America. The development of the drug discovery outsourcing industry in the region could be attributed to an increase in emphasis on discovering medicines for the treatment of COVID-19, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the growth of the drug discovery and development solutions industry.
Drug Discovery and Development Solutions: Market Segmentation
Drug discovery refers to the discovery of new medication and to the process of creating a therapeutically active substance for a particular target molecule or pathway. Drug discovery comprises of screening hits, medicinal chemistry, and optimisation of hits to reduce possible side effects of drugs. The discovery and development solutions of drugs together is a full process of identifying and introducing a new medication in the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The service types in the market can be divided into the following:
- Medicinal Chemistry
- Biology Services
- Drug Metabolism
- Pharmaceutical Services
- Pharmacokinetics
- Others
The drug types in the market can be divided into small molecules and biologics. The process types can be segmented as:
- Target Selection
- Target Validation
- Hit-To-Lead Identification
- Lead Optimisation
- Candidate Validation
- Others
The technology types in the industry can be segmented into the following:
- High Throughput Screening
- Biochips
- Pharmacogenetics
- Nanotechnology
- Spectroscopy
- Others
Based on therapeutic area, the market can be segmented into:
- Oncology
- Neurology
- Infectious and Immune System Diseases
- Digestive System Diseases
- Cardiovascular Diseases
- Others
The regional markets for drug discovery and development solutions can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising R&D Activities in the Pharmaceuticals Sector Bolstering the Market Growth for Drug Discovery and Development Solutions
The expansion of the demand for drug discovery outsourcing can be attributed to an increase in the emphasis on discovering medicines for the treatment of the rising COVID-19 pandemic, which has resulted in drug discovery outsourcing to companies equipped with AI technology. In addition, the growth in the investment in research and development (R&D) by major pharmaceutical and biotechnology firms and their emphasis on streamlining the internal costs of drug discovery outsourcing is fuelling the market growth. Developments in fundamental algorithms are used in computational information processing for predictive chemistry, which leads to improvements in scientific innovation and laboratory informatics. This is likely to increase the demand in the market in the coming years.
Key Industry Players in the Global Drug Discovery and Development Solutions Market
The report gives a detailed analysis of the following key players in the global drug discovery and development solutions market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Abbott Laboratories Inc.
- AstraZeneca plc
- Genentech, USA Inc
- Charles River Laboratories International, Inc.
- Gilead Sciences, Inc.
- Pfizer Inc.
- Jubilant Biosys Ltd.
- Sanofi SA
- F. Hoffmann-La Roche Ltd
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Service Type |
|
| Breakup by Drug Type |
|
| Breakup by Process |
|
| Breakup by Technology |
|
| Breakup by Mode |
|
| Breakup by Therapeutic Area |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Drug Discovery and Development Solutions Market Analysis
8.1 Key Industry Highlights
8.2 Global Drug Discovery and Development Solutions Historical Market (2018-2023)
8.3 Global Drug Discovery and Development Solutions Market Forecast (2024-2032)
8.4 Global Drug Discovery and Development Solutions Market by Service Type
8.4.1 Medicinal Chemistry
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Biology Services
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Drug Metabolism
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Pharmaceutical Services
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.5 Pharmacokinetics
8.4.5.1 Historical Trend (2018-2023)
8.4.5.2 Forecast Trend (2024-2032)
8.4.6 Others
8.5 Global Drug Discovery and Development Solutions Market by Drug Type
8.5.1 Small Molecules
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Biologics
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.6 Global Drug Discovery and Development Solutions Market by Process
8.6.1 Target Selection
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Target Validation
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Hit-To-Lead Identification
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Lead Optimisation
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Candidate Validation
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
8.6.6 Others
8.7 Global Drug Discovery and Development Solutions Market by Technology
8.7.1 High Throughput Screening
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Biochips
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Pharmacogenetics
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Nanotechnology
8.7.4.1 Historical Trend (2018-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Spectroscopy
8.7.5.1 Historical Trend (2018-2023)
8.7.5.2 Forecast Trend (2024-2032)
8.7.6 Others
8.8 Global Drug Discovery and Development Solutions Market by Mode
8.8.1 In-house
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Outsourced
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.9 Global Drug Discovery and Development Solutions Market by Therapeutic Area
8.9.1 Oncology
8.9.1.1 Historical Trend (2018-2023)
8.9.1.2 Forecast Trend (2024-2032)
8.9.2 Neurology
8.9.2.1 Historical Trend (2018-2023)
8.9.2.2 Forecast Trend (2024-2032)
8.9.3 Infectious and Immune System Diseases
8.9.3.1 Historical Trend (2018-2023)
8.9.3.2 Forecast Trend (2024-2032)
8.9.4 Digestive System Diseases
8.9.4.1 Historical Trend (2018-2023)
8.9.4.2 Forecast Trend (2024-2032)
8.9.5 Cardiovascular Diseases
8.9.5.1 Historical Trend (2018-2023)
8.9.5.2 Forecast Trend (2024-2032)
8.9.6 Others
8.10 Global Drug Discovery and Development Solutions Market by End Use
8.10.1 Hospital & Clinics
8.10.1.1 Historical Trend (2018-2023)
8.10.1.2 Forecast Trend (2024-2032)
8.10.2 Pharmaceutical Companies
8.10.2.1 Historical Trend (2018-2023)
8.10.2.2 Forecast Trend (2024-2032)
8.10.3 Biotechnology Companies
8.10.3.1 Historical Trend (2018-2023)
8.10.3.2 Forecast Trend (2024-2032)
8.10.4 Research Institute
8.10.4.1 Historical Trend (2018-2023)
8.10.4.2 Forecast Trend (2024-2032)
8.10.5 Others
8.11 Global Drug Discovery and Development Solutions Market by Region
8.11.1 North America
8.11.1.1 Historical Trend (2018-2023)
8.11.1.2 Forecast Trend (2024-2032)
8.11.2 Europe
8.11.2.1 Historical Trend (2018-2023)
8.11.2.2 Forecast Trend (2024-2032)
8.11.3 Asia Pacific
8.11.3.1 Historical Trend (2018-2023)
8.11.3.2 Forecast Trend (2024-2032)
8.11.4 Latin America
8.11.4.1 Historical Trend (2018-2023)
8.11.4.2 Forecast Trend (2024-2032)
8.11.5 Middle East and Africa
8.11.5.1 Historical Trend (2018-2023)
8.11.5.2 Forecast Trend (2024-2032)
9 North America Drug Discovery and Development Solutions Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Drug Discovery and Development Solutions Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Drug Discovery and Development Solutions Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Drug Discovery and Development Solutions Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Drug Discovery and Development Solutions Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Abbott Laboratories Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 AstraZeneca plc
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Genentech, USA Inc
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Charles River Laboratories International, Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Gilead Sciences, Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Pfizer Inc.
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Jubilant Biosys Ltd.
16.2.7.1 Company Overview
16.2.7.2 Product Portfolio
16.2.7.3 Demographic Reach and Achievements
16.2.7.4 Certifications
16.2.8 Sanofi SA
16.2.8.1 Company Overview
16.2.8.2 Product Portfolio
16.2.8.3 Demographic Reach and Achievements
16.2.8.4 Certifications
16.2.9 F. Hoffmann-La Roche Ltd
16.2.9.1 Company Overview
16.2.9.2 Product Portfolio
16.2.9.3 Demographic Reach and Achievements
16.2.9.4 Certifications
16.2.10 Others
17 Key Trends and Developments in the Market
1. Global Drug Discovery and Development Solutions Market: Key Industry Highlights, 2018 and 2032
2. Global Drug Discovery and Development Solutions Historical Market: Breakup by Service Type (USD Billion), 2018-2023
3. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Service Type (USD Billion), 2024-2032
4. Global Drug Discovery and Development Solutions Historical Market: Breakup by Drug Type (USD Billion), 2018-2023
5. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Drug Type (USD Billion), 2024-2032
6. Global Drug Discovery and Development Solutions Historical Market: Breakup by Process (USD Billion), 2018-2023
7. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Process (USD Billion), 2024-2032
8. Global Drug Discovery and Development Solutions Historical Market: Breakup by Technology (USD Billion), 2018-2023
9. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Technology (USD Billion), 2024-2032
10. Global Drug Discovery and Development Solutions Historical Market: Breakup by Mode (USD Billion), 2018-2023
11. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Mode (USD Billion), 2024-2032
12. Global Drug Discovery and Development Solutions Historical Market: Breakup by Therapeutical Area (USD Billion), 2018-2023
13. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Therapeutical Area (USD Billion), 2024-2032
14. Global Drug Discovery and Development Solutions Historical Market: Breakup by End Use (USD Billion), 2018-2023
15. Global Drug Discovery and Development Solutions Market Forecast: Breakup by End Use (USD Billion), 2024-2032
16. Global Drug Discovery and Development Solutions Historical Market: Breakup by Region (USD Billion), 2018-2023
17. Global Drug Discovery and Development Solutions Market Forecast: Breakup by Region (USD Billion), 2024-2032
18. North America Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2018-2023
19. North America l Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Europe Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Europe Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Asia Pacific Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2018-2023
23. Asia Pacific Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2024-2032
24. Latin America Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2018-2023
25. Latin America Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2024-2032
26. Middle East and Africa Drug Discovery and Development Solutions Historical Market: Breakup by Country (USD Billion), 2018-2023
27. Middle East and Africa Drug Discovery and Development Solutions Market Forecast: Breakup by Country (USD Billion), 2024-2032
28. Global Drug Discovery and Development Solutions Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 13% between 2024 and 2032.
The growth of the market is being driven by the growing population, expanding healthcare sector, increasing disposable incomes, and the thriving pharmaceuticals sector.
The increasing demand for outsourcing analytical testing services and growing research and development activities are the key trends guiding the growth of the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The different service types in the market are medicinal chemistry, biology services, drug metabolism, pharmaceutical services, and pharmacokinetics, among others.
The major drug types in the market are small molecules and biologics.
The significant processes in the market are target selection, target validation, hit-to-lead identification, lead optimisation, and candidate validation, among others.
The various technology types in the market are high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy, among others.
The major therapeutic areas in the market are oncology, neurology, infectious and immune system diseases, digestive system diseases, and cardiovascular diseases, among others.
The major players in the global drug discovery and development solutions market are Abbott Laboratories Inc., AstraZeneca plc, Genentech, USA Inc, Charles River Laboratories International, Inc., Gilead Sciences, Inc., Pfizer Inc., Jubilant Biosys Ltd., Sanofi SA, and F. Hoffmann-La Roche Ltd, among others.
Analyst Review
The global drug discovery and development solutions market is being driven by the rising healthcare sector. Aided by the growing R&D activities, the market is expected to witness a robust growth in the forecast period of 2024-2032, growing at a CAGR of 13%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on service types, the market is segmented into medicinal chemistry, biology services, drug metabolism, pharmaceutical services, and pharmacokinetics, among others. On the basis of drug type, the industry is bifurcated into small molecules and biologics. By process types, the market is categorised into target selection, target validation, hit-to-lead identification, lead optimisation, and candidate validation, among others. Based on technology type, the industry is segmented into high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy, among others. On the basis of therapeutic area, the market is divided into oncology, neurology, infectious and immune system diseases, digestive system diseases, and cardiovascular diseases, among others. The major regional markets for drug discovery and development solutions are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories Inc., AstraZeneca plc, Genentech, USA Inc, Charles River Laboratories International, Inc., Gilead Sciences, Inc., Pfizer Inc., Jubilant Biosys Ltd., Sanofi SA, and F. Hoffmann-La Roche Ltd, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER